Search

pSivida to raise $29m to fund clinical trials

Perth headquartered bio-nanotech company pSivida Ltd is looking to raise $29 million through a non-renounceable rights issue to fund clinical trials for two of its treatments.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer